HomeACST • NASDAQ
Follow
Acasti Pharma Inc
Previous close
$3.40
Day range
$3.37 - $3.43
Year range
$1.72 - $3.84
Market cap
32.19M USD
Avg Volume
35.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.04M | -28.32% |
Net income | -2.39M | 38.52% |
Net profit margin | — | — |
Earnings per share | -0.28 | -135.30% |
EBITDA | -3.04M | 28.17% |
Effective tax rate | 8.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 25.11M | -19.65% |
Total assets | 76.18M | -34.77% |
Total liabilities | 11.50M | -42.71% |
Total equity | 64.68M | — |
Shares outstanding | 9.40M | — |
Price to book | 0.49 | — |
Return on assets | -9.85% | — |
Return on capital | -11.57% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.39M | 38.52% |
Cash from operations | -1.89M | 49.17% |
Cash from investing | -6.55M | -31.05% |
Cash from financing | 0.00 | — |
Net change in cash | -8.45M | 2.75% |
Free cash flow | -1.07M | 51.02% |
About
Founded
2002
Website
Employees
32